Was Karen Marie Leggio’s Ryerson (RYI) share grant an open-market purchase?

No, the 389 Ryerson shares were granted as equity compensation, not bought in the market. The Form 4 labels the transaction as a grant or award, with a zero dollar per-share price, indicating it is part of the company’s Director Compensation Program rather than a discretionary purchase.

Ryerson director granted 389 shares as equity pay

Ryerson Holding Corp director Karen Marie Leggio received an equity grant of 389 shares of common stock as compensation.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Ryerson Holding Corp director Karen Marie Leggio received an equity grant of 389 shares of common stock as compensation. The award was issued under Ryerson's Director Compensation Program, vested in full on the grant date, and carried no cash exercise price.

Following this grant, Leggio directly holds 5,272 shares of Ryerson common stock. This is a routine stock-based compensation award rather than an open-market share purchase or sale.

Insider Trade Summary

Grant/Award: 389 shares

Grant/Award 1 txn

Insider Leggio Karen Marie

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock (par value $0.01 per share)	389	$0.00	$0.00

Holdings After Transaction: Common Stock (par value $0.01 per share) — 5,272 shares (Direct)

Footnotes (1)

F1. Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date.

Key Figures

Equity grant size: 389 shares Grant price: $0.00 per share Post-grant holdings: 5,272 shares

3 metrics

Equity grant size 389 shares Common stock awarded as director compensation

Grant price $0.00 per share Non-cash equity award under Director Compensation Program

Post-grant holdings 5,272 shares Total Ryerson common stock held directly after grant

Key Terms

Director Compensation Program, equity, Grant, award, or other acquisition, Common Stock (par value $0.01 per share)

4 terms

Director Compensation Program financial

"Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program."

equity financial

"Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program."

Equity is an ownership stake in a company, usually represented by shares, that gives the owner a claim on the company’s profits and on its assets after debts are paid. For investors, equity matters because its value rises and falls with the company’s performance, determines potential dividend income and voting influence, and represents both the upside (growth) and the risk (loss) of owning a slice of the business, like owning a piece of a pie whose size can change.

Grant, award, or other acquisition financial

"transaction_code_description": "Grant, award, or other acquisition""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Ryerson (RYI) director Karen Marie Leggio report?

Karen Marie Leggio reported receiving 389 shares of Ryerson common stock as an equity grant. The shares were awarded as director compensation, vested in full on the grant date, and increased her direct holdings to 5,272 shares, with no open-market buying or selling involved.

How many Ryerson (RYI) shares does Karen Marie Leggio hold after this grant?

After the equity grant, Karen Marie Leggio directly holds 5,272 Ryerson common shares. This figure comes from the post-transaction ownership line in the Form 4, which updates her holdings to include the 389 shares granted as director compensation on the reported grant date.

What does the Ryerson Director Compensation Program provide to Karen Marie Leggio?

Under Ryerson’s Director Compensation Program, Karen Marie Leggio received 389 shares of common stock as equity compensation. A footnote explains that this award represents director pay in stock form and that the shares vested in full immediately on the grant date, giving her full ownership at once.

Did the Ryerson (RYI) director pay anything for the 389 granted shares?

No, the reported per-share price for the 389 granted Ryerson shares is listed as $0.00. This confirms the transaction is a non-cash equity award provided as part of director compensation, rather than a purchase requiring the director to pay cash for the shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Accepted by SEC EDGAR 04/13/2026 - 08:38 PM EDT

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Leggio Karen Marie

(Last)

(First)

(Middle)

C/O RYERSON HOLDING CORP.

227 W. MONROE ST., 27TH FLOOR

(Street)

CHICAGO

ILLINOIS

60606

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ryerson Holding Corp [ RYZ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock (par value $0.01 per share)	04/10/2026		A		389⁽¹⁾	A	$0	5,272	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects compensation in the form of equity received pursuant to Ryerson's Director Compensation Program. The award vested in full on the grant date.

	/s/ Camilla Rykke Merrick, attorney-in-fact	04/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR